The effect on the female foetus of prolonged treatment with 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate (MAP) during pregnancy.
D019326:17-alpha-Hydroxyprogesterone; D000085:Acetates; D005260:Female; D005333:Fetus; D006801:Humans; D011247:Pregnancy; D011372:Progestins; D014770:Virilism
D000085:Acetates; D011372:Progestins; D019326:17-alpha-Hydroxyprogesterone
FETUS; PREGNANCY; PROGESTATIONAL HORMONES; VIRILISM